/Rheinland Biotechnology: January-June 2026 - Summary table of non-operating fund occupation and other related fund transactions
NEWS

Rheinland Biotechnology: January-June 2026 - Summary table of non-operating fund occupation and other related fund transactions

Shenzhen Stock Exchange
2026/08/29

Summary table of non-operating fund occupation and other related fund transactions of Guilin Rhine Biotechnology Co., Ltd. from January to June 2026. Compilation unit: Guilin Rhine Biotechnology Co., Ltd. Unit: Yuan Total occupation in 2026

The occupier and the listed company Accounting of the listed company Occupied at the beginning of 2026 Occupied funds in 2026 Repay the accumulated funds in 2026 Occupied non-operating funds at the end of June 2026 Name of the occupier of funds Accounting account account balance of funds (not related relationship of occupancy company) Interest on funds (if any) The amount of funds used Reasons for the occurrence

including interest)

Controlling shareholder, actual control

people and their affiliated companies

Subtotal

Former controlling shareholder, actual controlling shareholder

Co., Ltd. and its affiliated companies

Subtotal

Other related parties and subsidiaries

industry

Subtotal

total

Exhausted for 2026

Correspondence parties and listed companies Accounting of listed companies Accounting account of other related fund transactions accounted for at the beginning of 2026 Capital occupied in 2026 Repayment in 2026 Accounted for at the end of June 2026 Other related fund transactions Name of fund counterparty Accounting account Accounting amount incurred (related relationship without transaction nature) Fund balance Interest on funds (if any) Calculated amount incurred Reasons for use of fund balance

including interest)

Controlling shareholder, actual control

people and their affiliated companies

Subsidiaries of listed companies and

  • Its affiliated companies

Other related parties and their subsidiaries

enterprise

Total - - - - - - - - - - - This table was approved by the 14th meeting of the 7th Board of Directors on August 28, 2026.

Legal representative of the company: Zheng Hui Person in charge of accounting work: Zheng Hui Person in charge of the company’s accounting department: Zhang Weipeng